Tactile Systems Technology (TCMD) Cash from Operations Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -7.20% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 132.40% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 6.69% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -35.67% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -84.38% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 122.43% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 185.96% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 16.00% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 28.60% |
| 10 | Tactile Systems Technology | 539.21 Mn | 449.02 Mn | 57.61 Mn | -181.29% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -181.29% |
| Dec 31, 2025 | 5.90% |
| Sep 30, 2025 | 0.83% |
| Jun 30, 2025 | 12.29% |
| Mar 31, 2025 | -54.87% |
| Dec 31, 2024 | -11.00% |
| Sep 30, 2024 | 150.39% |
| Jun 30, 2024 | -5.51% |
| Mar 31, 2024 | 284.06% |
| Dec 31, 2023 | 376.06% |
| Sep 30, 2023 | 81.72% |
| Jun 30, 2023 | 503.17% |
| Mar 31, 2023 | 84.34% |
| Dec 31, 2022 | -31.23% |
| Sep 30, 2022 | 313.04% |
| Jun 30, 2022 | 306.45% |
| Mar 31, 2022 | -300.75% |
| Dec 31, 2021 | 11.25% |
| Sep 30, 2021 | -118.45% |
| Jun 30, 2021 | 87.43% |
| Mar 31, 2021 | -188.01% |
| Dec 31, 2020 | 5,561.80% |
| Sep 30, 2020 | 265.29% |
| Jun 30, 2020 | -2,006.40% |
| Mar 31, 2020 | -28.59% |
| Dec 31, 2019 | -98.33% |
| Sep 30, 2019 | -69.11% |
| Jun 30, 2019 | -154.52% |
| Mar 31, 2019 | 158.58% |
| Dec 31, 2018 | 27.99% |
| Sep 30, 2018 | 66.77% |
| Jun 30, 2018 | 128.68% |
| Mar 31, 2018 | -587.66% |
| Dec 31, 2017 | 54.21% |
| Sep 30, 2017 | -16.83% |
| Jun 30, 2017 | -276.75% |
| Mar 31, 2017 | 63.08% |
| Dec 31, 2016 | 5.15% |
| Sep 30, 2016 | 804.94% |